IBI3009
-
【Product for Licensing】DLL3 ADC！Two >1B licensing deals by Hengrui/IDEAYA Bio and Innovent Bio/Roche in just 4 days
If you are interested in similar assets, please contact DrugTimes BD Team at BD@drugtimes.cn asap. Many thanks!
-
信达生物与罗氏达成新一代DLL3抗体偶联药物的全球独家许可协议
热烈祝贺信达生物和罗氏！
